# ![@medtechmd Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::329402736.png) @medtechmd Will

Will posts on X about $tmdx, $abt, $npce, $lnth the most. They currently have [---] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: [--] [#](/creator/twitter::329402736/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:interactions.svg)

- [--] Week [-----] +113%
- [--] Month [------] -45%
- [--] Months [-------] -12%
- [--] Year [-------] -5.30%

### Mentions: [--] [#](/creator/twitter::329402736/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:posts_active.svg)

- [--] Week [--] -13%
- [--] Month [--] -4.80%
- [--] Months [---] +17%
- [--] Year [---] +41%

### Followers: [---] [#](/creator/twitter::329402736/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:followers.svg)

- [--] Week [---] no change
- [--] Month [---] +0.80%
- [--] Months [---] +14%
- [--] Year [---] +31%

### CreatorRank: [---------] [#](/creator/twitter::329402736/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  39.69% [finance](/list/finance)  8.4% [cryptocurrencies](/list/cryptocurrencies)  6.87% [countries](/list/countries)  3.82% [technology brands](/list/technology-brands)  0.76% [travel destinations](/list/travel-destinations)  0.76% [automotive brands](/list/automotive-brands)  0.76%

**Social topic influence**
[$tmdx](/topic/$tmdx) 22.14%, [$abt](/topic/$abt) 11.45%, [$npce](/topic/$npce) #1, [$lnth](/topic/$lnth) 6.87%, [$edap](/topic/$edap) #2, [$huma](/topic/$huma) 6.11%, [$mbx](/topic/$mbx) 4.58%, [$bmy](/topic/$bmy) 3.82%, [$xyl](/topic/$xyl) #3, [freestyle](/topic/freestyle) 3.05%

**Top accounts mentioned or mentioned by**
[@ucirvinehealth](/creator/undefined) [@drsumeetvadera](/creator/undefined) [@bobhugin](/creator/undefined) [@focalonehifu](/creator/undefined) [@clevelandclinic](/creator/undefined) [@ccad](/creator/undefined) [@robmtaub](/creator/undefined) [@scaramucci](/creator/undefined) [@billackman](/creator/undefined) [@nightowlbiotech](/creator/undefined) [@thelancet](/creator/undefined) [@bcmsurgery](/creator/undefined) [@texasheart](/creator/undefined) [@bcmlunginst](/creator/undefined) [@revshark](/creator/undefined) [@mvillavicenciot](/creator/undefined) [@tpusa](/creator/undefined) [@pharmavoice](/creator/undefined) [@reformedbroker](/creator/undefined) [@linzy_long_hold](/creator/undefined)

**Top assets mentioned**
[TransMedics Group, Inc. Common Stock (TMDX)](/topic/$tmdx) [Arcblock (ABT)](/topic/$abt) [NeuroPace Inc (NPCE)](/topic/$npce) [Lantheus Holdings, Inc (LNTH)](/topic/$lnth) [Huma Finance (HUMA)](/topic/$huma) [Marblex (MBX)](/topic/$mbx) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Xylem Inc (XYL)](/topic/$xyl) [Rapport Therapeutics, Inc. (RAPP)](/topic/$rapp) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Eli Lilly and Company (LLY)](/topic/$lly) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [Exact Sciences Corp (EXAS)](/topic/$exas) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Novo-Nordisk (NVO)](/topic/$nvo) [NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)](/topic/$nams) [Akropolis (AKRO)](/topic/$akro) [Pfizer, Inc. (PFE)](/topic/$pfe) [AbbVie Inc (ABBV)](/topic/$abbv) [Nuvation Bio Inc. (NUVB)](/topic/$nuvb) [Immunocore Holdings Limited (IMCR)](/topic/$imcr) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Boston Scientific Corporation (BSX)](/topic/boston-scientific) [Basilisk (BSX)](/topic/$bsx) [UnitedHealth Group (UNH)](/topic/$unh) [Procter & Gamble (PG)](/topic/$pg) [DexCom, Inc. (DXCM)](/topic/$dxcm) [United Therapeutics, Corp. (UTHR)](/topic/$uthr) [Constellation Brands, Inc. Class A (STZ)](/topic/$stz) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [Blackstone, Inc. (BX)](/topic/$bx) [Walmart, Inc. (WMT)](/topic/$wmt) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Microsoft Corp. (MSFT)](/topic/$msft) [Jefferies Financial Group Inc. (JEF)](/topic/$jef)
### Top Social Posts
Top posts by engagements in the last [--] hours

"$NUVB founder David Hung on his way to second successful biotech company"  
[X Link](https://x.com/medtechmd/status/2016141492612411747)  2026-01-27T13:29Z [---] followers, [---] engagements


"$EDAP Receives HIFU Reimbursement for Prostate Cancer in France. As one of the largest healthcare markets in Europe securing reimbursement in France is likely to accelerate reimbursement for Focal One Robotic HIFU in additional European countries. https://investor.focalone.com/news-releases/news-release-details/edap-receives-hifu-reimbursement-prostate-cancer-france https://investor.focalone.com/news-releases/news-release-details/edap-receives-hifu-reimbursement-prostate-cancer-france"  
[X Link](https://x.com/medtechmd/status/1965011135385501968)  2025-09-08T11:15Z [---] followers, [---] engagements


"$IMCR: Jefferies take post healthcare conference presentation:"  
[X Link](https://x.com/medtechmd/status/1991315979218170232)  2025-11-20T01:21Z [---] followers, [---] engagements


"Former UK Prime Minister Treated With $EDAP Focal One HIFU For Prostate Cancer"  
[X Link](https://x.com/medtechmd/status/1995947065546056175)  2025-12-02T20:03Z [---] followers, [---] engagements


"Excerpt from Jefferies note on differentiation between $KURA Ziftomenib vs $SNDX Revumenib"  
[X Link](https://x.com/medtechmd/status/1999447557303685200)  2025-12-12T11:53Z [---] followers, [----] engagements


"It sees limited negative readthrough to $XENE depression study from $BHVN miss"  
[X Link](https://x.com/medtechmd/status/2004544764864295340)  2025-12-26T13:28Z [---] followers, [----] engagements


"I truly believe it represents the future of prostate cancer treatment when the disease can be discovered early. $EDAP Focal One Gaining Traction In the Treatment Of Prostate Cancer. St. Clair now offers Robotic Focal High-Intensity Focused Ultrasound (HIFU) a treatment option for prostate cancer. Kevin Bordeau MD recently performed our first HIFU procedure making us the first in the region to offer this technology. Learn more: https://t.co/17kEigsY7W https://t.co/aazFy5OkdV St. Clair now offers Robotic Focal High-Intensity Focused Ultrasound (HIFU) a treatment option for prostate cancer."  
[X Link](https://x.com/medtechmd/status/2015734809008456028)  2026-01-26T10:33Z [---] followers, [---] engagements


"$XYL initiated Outperform as pure water solutions company"  
[X Link](https://x.com/medtechmd/status/2015737323665653824)  2026-01-26T10:43Z [---] followers, [---] engagements


"$EDAP Focal One HIFU Efficacious In Endometriosis"  
[X Link](https://x.com/medtechmd/status/2017809872679481752)  2026-02-01T03:58Z [---] followers, [---] engagements


"$EXAS Soon To Be A Part Of $ABT Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests. https://investor.exactsciences.com/investor-relations/press-releases/press-release-details/2026/Exact-Sciences-Applauds-Passage-of-Legislation-Establishing-Medicare-Coverage-Pathway-for-Multi-Cancer-Early-Detection-Tests/default.aspx"  
[X Link](https://x.com/medtechmd/status/2018774915835629776)  2026-02-03T19:53Z [---] followers, [---] engagements


"Jefferies commentary regarding prospects for $XENE focal epilepsy drug"  
[X Link](https://x.com/medtechmd/status/2021374109582839958)  2026-02-11T00:01Z [---] followers, [---] engagements


"$EDAP Announces Appointment of David Horn to Board of Directors Focal One Experienced US markets individual added to board of directors. https://investor.focalone.com/news-releases/news-release-details/edap-announces-appointment-david-horn-board-directors https://investor.focalone.com/news-releases/news-release-details/edap-announces-appointment-david-horn-board-directors"  
[X Link](https://x.com/medtechmd/status/2021927118897074567)  2026-02-12T12:39Z [---] followers, [---] engagements


"100 $NPCE RNS system cases completed at UC Irvine. 👏 Big milestone for @ucirvinehealth: [---] RNS System cases completed Congrats to Dr. Sumeet Vadera (@drsumeetvadera) and the epilepsy team at UCI for bringing cutting-edge devices precision medicine and patient-centered care for people living with #epilepsy. 💙 #DRE https://t.co/y4C8diaGom 👏 Big milestone for @ucirvinehealth: [---] RNS System cases completed Congrats to Dr. Sumeet Vadera (@drsumeetvadera) and the epilepsy team at UCI for bringing cutting-edge devices precision medicine and patient-centered care for people living with"  
[X Link](https://x.com/medtechmd/status/2022040945500508262)  2026-02-12T20:11Z [---] followers, [---] engagements


"Water management becomes mainstream: $XYL"  
[X Link](https://x.com/medtechmd/status/1983127597530722538)  2025-10-28T11:03Z [---] followers, [----] engagements


"$XYL raises revenue and EPS as water management becomes mainstream. Water management becomes mainstream: $XYL https://t.co/IyXFFhkbx3 Water management becomes mainstream: $XYL https://t.co/IyXFFhkbx3"  
[X Link](https://x.com/medtechmd/status/1983127847850869009)  2025-10-28T11:04Z [---] followers, [---] engagements


"$RAPP : Very Targeted Molecule In Focal Epilepsy Gleaned From Study In Patients W/ Implanted $NPCE RNS System"  
[X Link](https://x.com/medtechmd/status/1998353446240399706)  2025-12-09T11:26Z [---] followers, [---] engagements


"$NPCE price target raised to $22 from $18 at UBS with a Buy rating on shares"  
[X Link](https://x.com/medtechmd/status/2000912002894430615)  2025-12-16T12:52Z [---] followers, [---] engagements


"$NPCE : Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year [----] and Initial [----] Outlook. PMA supplement for idiopathic generalized epilepsy w/ tonic clonic seizures submitted to the FDA. Revenues not accounted for in guidance https://investors.neuropace.com/news/news-details/2026/NeuroPace-Reports-Preliminary-Unaudited-Results-for-the-Fourth-Quarter-and-Fiscal-Year-2025-and-Initial-2026-Outlook/default.aspx"  
[X Link](https://x.com/medtechmd/status/2011057024612683784)  2026-01-13T12:45Z [---] followers, [---] engagements


"Boston Scientific ( $BSX ) to acquire Penumbra for $374 per share in cash and stock. Medical Device space has a lot of candidates for M&A. $TMDX $NPCE $EDAP"  
[X Link](https://x.com/medtechmd/status/2011774408407605447)  2026-01-15T12:16Z [---] followers, [---] engagements


"$NPCE RNS System For The Treatment Of Drug Resistant Focal Epilepsy & Soon Generalized Epilepsy: IMHO A Prime Medtech M&A Candidate"  
[X Link](https://x.com/medtechmd/status/2016109141798891560)  2026-01-27T11:20Z [---] followers, [---] engagements


"$NPCE : At Prisma Health: As South Carolina's largest private non-profit healthcare system Prisma Health is here to create a better state of health for South Carolinians"  
[X Link](https://x.com/medtechmd/status/2016247547950428468)  2026-01-27T20:30Z [---] followers, [---] engagements


"Expanding Neurostimulation and Gene Therapy Possibilities Johns Hopkins Medicine Hopkins highlights $NPCE RNS closed loop device to treat drug resistant Epilepsy. https://www.hopkinsmedicine.org/news/articles/2025/12/expanding-neurostimulation-and-gene-therapy-possibilities https://www.hopkinsmedicine.org/news/articles/2025/12/expanding-neurostimulation-and-gene-therapy-possibilities"  
[X Link](https://x.com/medtechmd/status/2016890468613730588)  2026-01-29T15:05Z [---] followers, [---] engagements


"$HUMA Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels. Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels. https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-new-us-department-defense-funding-procurement/ https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-new-us-department-defense-funding-procurement/"  
[X Link](https://x.com/medtechmd/status/2020846726395879787)  2026-02-09T13:06Z [---] followers, [----] engagements


"Jefferies commentary regarding prospects for $RAPP focal epilepsy drug. A number of molecules with data readouts in this active space"  
[X Link](https://x.com/medtechmd/status/2021375903591440876)  2026-02-11T00:09Z [---] followers, [---] engagements


"@BobHugin So Bob (Jeff Flake) Hugin the NJ RINO again responds to this issue with a politically correct response. Dont count on him to support the Trump agenda. He will be the consummate politician if he makes it to Washington youll see"  
[X Link](https://x.com/medtechmd/status/1045475351277785088)  2018-09-28T00:48Z [---] followers, [--] engagements


"$TMDX CFO Presented At Canaccord Healthcare Conference This Morning. Last Question From Analyst After Bullish Fireside Chat: Who Would Buy You Answer From CEO Stephen Gordon; We Are Not Running The Company To Be Acquired"  
[X Link](https://x.com/anyuser/status/1823360485879677129)  2024-08-13T14:06Z [---] followers, [----] engagements


"$NPCE : Very good extended data readout in drug resistant focal epilepsy. Company has executed on all measures"  
[X Link](https://x.com/medtechmd/status/1998733052936151049)  2025-12-10T12:34Z [---] followers, [---] engagements


"$NPCE RNS system [--] year post approval study in focal epilepsy vs [--] other platforms. Huge delta in seizure reduction in favor of NPCE RNS"  
[X Link](https://x.com/medtechmd/status/1999566945058750601)  2025-12-12T19:48Z [---] followers, [---] engagements


"$NPCE #Files PMA Supplement to FDA Seeking Expanded RNS System Indication for Idiopathic Generalized Epilepsy. Unlike focal epilepsy patients with drug-resistant IGE have no approved alternative treatment options. https://investors.neuropace.com/news/news-details/2025/NeuroPace-Files-PMA-Supplement-to-FDA-Seeking-Expanded-RNS-System-Indication-for-Idiopathic-Generalized-Epilepsy/default.aspx https://investors.neuropace.com/news/news-details/2025/NeuroPace-Files-PMA-Supplement-to-FDA-Seeking-Expanded-RNS-System-Indication-for-Idiopathic-Generalized-Epilepsy/default.aspx"  
[X Link](https://x.com/medtechmd/status/2001278371158753580)  2025-12-17T13:08Z [---] followers, [---] engagements


"$NPCE : $100 million in revenue in [----]. Gross margin: 77.2% RNS revenue: $81.7 million 25% YOY growth"  
[X Link](https://x.com/medtechmd/status/2011576296674083187)  2026-01-14T23:08Z [---] followers, [---] engagements


"$EXAS : Announces Record Fourth Quarter and Full Year [----] Results. Soon to be an $ABT company. https://investor.exactsciences.com/investor-relations/press-releases/press-release-details/2026/Exact-Sciences-Announces-Record-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx https://investor.exactsciences.com/investor-relations/press-releases/press-release-details/2026/Exact-Sciences-Announces-Record-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx"  
[X Link](https://x.com/medtechmd/status/2022420032509161704)  2026-02-13T21:18Z [---] followers, [---] engagements


"$ABT best managed and diversified global healthcare company. $ABT has increased its dividend payout for [--] consecutive years & is a member of the S&P [---] Dividend Aristocrats which tracks companies that have annually increased their dividend for at least [--] consecutive years. $ABT Q1 [----] Results: In Diabetes Care sales of continuous glucose monitors (FreeStyle Libre) were $1.7 billion and grew [----] percent on a reported basis and [----] percent on an organic basis. WW Medical Devices sales increased 9.9% on a reported basis and 12.6% organic basis $ABT Q1 [----] Results: In Diabetes Care sales"  
[X Link](https://x.com/medtechmd/status/1912513515258077383)  2025-04-16T14:28Z [---] followers, [---] engagements


"Remote $EDAP Focal One HIFU Prostate Cancer procedure performed between Cleveland Clinic Ohio & Cleveland Clinic UAE. Focal therapy gaining traction. Worlds First Remote Transatlantic @FocalOneHIFU Focal Therapy Procedure for Prostate Cancer was successfully performed between @ClevelandClinic Ohio in the United States and @CCAD in the United Arab Emirates two hospitals that are separated by over [-----] km (7000 miles). Worlds First Remote Transatlantic @FocalOneHIFU Focal Therapy Procedure for Prostate Cancer was successfully performed between @ClevelandClinic Ohio in the United States and"  
[X Link](https://x.com/medtechmd/status/1912615140928942143)  2025-04-16T21:12Z [---] followers, [---] engagements


"$ABT: [--] price targets raised by the sell side in the last [--] hours post Abbott quarterly earnings report. The best managed and diversified global Medtech/Healthcare company"  
[X Link](https://x.com/medtechmd/status/1912841492869124256)  2025-04-17T12:12Z [---] followers, [---] engagements


"Twenty patients have returned to Royal Papworth Hospital in Cambridge to celebrate [--] years of a new type of heart transplant DCD which saved their lives. Papworth championed early use of $TMDX OCS in DCD transplant & showed [--] year durability. https://search.app/TBGTDMGCqVmyjsJ37 https://search.app/TBGTDMGCqVmyjsJ37"  
[X Link](https://x.com/medtechmd/status/1915211791837077831)  2025-04-24T01:10Z [---] followers, [---] engagements


"The case for Focal Therapy in Prostate Cancer at AUA25. $EDAP Focal One. Focal therapy = effective less invasive better QOL. AUA25"  
[X Link](https://x.com/medtechmd/status/1916643849218256990)  2025-04-28T00:01Z [---] followers, [---] engagements


"$LNTH Competitor $TLX Receives CRL For Glioma Diagnostic. Not So Fast Says FDA Formal Clinical Trial Required"  
[X Link](https://x.com/medtechmd/status/1916786749264531694)  2025-04-28T09:29Z [---] followers, [---] engagements


"$LNTH Announces Alzheimers Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints. The development of MK-6240 complements Lantheus amyloid PET imaging agent NAV-4694 (F18-flutafuranol) which is currently in Phase [--] development. https://investor.lantheus.com/news-releases/news-release-details/lantheus-announces-alzheimers-disease-radiodiagnostic-mk-6240 https://investor.lantheus.com/news-releases/news-release-details/lantheus-announces-alzheimers-disease-radiodiagnostic-mk-6240"  
[X Link](https://x.com/medtechmd/status/1917571783605342374)  2025-04-30T13:28Z [---] followers, [---] engagements


"MotoAmerica Becomes First Sports Organization to Use $ABT Rapid Blood Test for Concussion Evaluation On-site at Races. Will contact sports including NFL follow suit in the future https://www.prnewswire.com/news-releases/motoamerica-becomes-first-sports-organization-to-use-abbotts-rapid-blood-test-for-concussion-evaluation-on-site-at-races-302444065.html https://www.prnewswire.com/news-releases/motoamerica-becomes-first-sports-organization-to-use-abbotts-rapid-blood-test-for-concussion-evaluation-on-site-at-races-302444065.html"  
[X Link](https://x.com/medtechmd/status/1917930045881852254)  2025-05-01T13:12Z [---] followers, [---] engagements


"@robmtaub @Scaramucci He is a joke. Trying to make himself relevant on a short lived White House job he was fired from"  
[X Link](https://x.com/medtechmd/status/1919729661950533738)  2025-05-06T12:23Z [---] followers, [--] engagements


"Jefferies analyst doesnt seem overly concerned regarding $LNTH quarter and competitive pressures. Price target reduced from $140.00 to $130.00 and maintained at Buy. Management is diversifying the business in the Radiopharma space in all aspects"  
[X Link](https://x.com/medtechmd/status/1920220292758073755)  2025-05-07T20:52Z [---] followers, [----] engagements


"$LNTH: Further dialogue from Jefferies on quarterly performance. Jefferies analyst doesnt seem overly concerned regarding $LNTH quarter and competitive pressures. Price target reduced from $140.00 to $130.00 and maintained at Buy. Management is diversifying the business in the Radiopharma space in all aspects. https://t.co/9j7epGQKea Jefferies analyst doesnt seem overly concerned regarding $LNTH quarter and competitive pressures. Price target reduced from $140.00 to $130.00 and maintained at Buy. Management is diversifying the business in the Radiopharma space in all aspects."  
[X Link](https://x.com/medtechmd/status/1920220838034276824)  2025-05-07T20:54Z [---] followers, [----] engagements


"We reiterate our Buy rating viewing the base business as still undervalued with potential upside from the pipeline. We are lowering our PT and #s to account for lower PYL sales and Evergreen EPS dilution. Our new PT of $130. $LNTH Jefferies analyst doesnt seem overly concerned regarding $LNTH quarter and competitive pressures. Price target reduced from $140.00 to $130.00 and maintained at Buy. Management is diversifying the business in the Radiopharma space in all aspects. https://t.co/9j7epGQKea Jefferies analyst doesnt seem overly concerned regarding $LNTH quarter and competitive pressures."  
[X Link](https://x.com/medtechmd/status/1920221564332650606)  2025-05-07T20:57Z [---] followers, [---] engagements


"$LNTH price target to $120 from $134.00. This company is a leader in the highly specialized Radiopharmaceutical space"  
[X Link](https://x.com/medtechmd/status/1920488990462882243)  2025-05-08T14:40Z [---] followers, [----] engagements


"Mayo Clinic the number one rated healthcare system in the world comments on innovations which have changed the organ transplantation dynamic. $TMDX OCS NOP"  
[X Link](https://x.com/medtechmd/status/1921406592789946476)  2025-05-11T03:26Z [---] followers, [----] engagements


"$TMDX OCS NOP Machine Perfusion Has Decreased Waiting List Times & Increased Organ Utilization Through DCD & Extended DBD Transplants. Mayo Clinic the number one rated healthcare system in the world comments on innovations which have changed the organ transplantation dynamic. $TMDX OCS NOP https://t.co/ZbCRY6ZoPe Mayo Clinic the number one rated healthcare system in the world comments on innovations which have changed the organ transplantation dynamic. $TMDX OCS NOP https://t.co/ZbCRY6ZoPe"  
[X Link](https://x.com/medtechmd/status/1921515331077509603)  2025-05-11T10:38Z [---] followers, [----] engagements


"$UNH: Vanguard of the industry falls from grace accompanied by CEO change. @BillAckman on top of this early on"  
[X Link](https://x.com/medtechmd/status/1922248280735436828)  2025-05-13T11:11Z [---] followers, [----] engagements


"We are encouraged by the continued strength of our commercial execution to start [----] w/revenue growth driven by an expanding base of prescribing physicians and increasing traction from our Project CARE initiative. $NPCE RNS System Gaining Traction In Drug Resistant Epilepsy"  
[X Link](https://x.com/medtechmd/status/1922384996431540722)  2025-05-13T20:14Z [---] followers, [---] engagements


""These results are remarkable as we see dual benefits from CGM technology in managing diabetes. CGMs empower people to proactively manage their diabetes and make informed health choices through real-time constant feedback on their glucose levels. $ABT https://www.prnewswire.com/news-releases/abbotts-libre-technology-is-first-continuous-glucose-monitor-associated-with-reduced-hospitalizations-for-heart-complications-in-people-with-diabetes-302456611.html"  
[X Link](https://x.com/medtechmd/status/1923005791386087753)  2025-05-15T13:21Z [---] followers, [---] engagements


"$ABT Receives FDA Approval for Tendyne First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery https://www.prnewswire.com/news-releases/abbott-receives-fda-approval-for-tendyne-first-of-its-kind-device-to-replace-the-mitral-valve-without-open-heart-surgery-302464432.html https://www.prnewswire.com/news-releases/abbott-receives-fda-approval-for-tendyne-first-of-its-kind-device-to-replace-the-mitral-valve-without-open-heart-surgery-302464432.html"  
[X Link](https://x.com/medtechmd/status/1927350564930703370)  2025-05-27T13:05Z [---] followers, [---] engagements


"$NPCE coverage initiated by HCW: Focal epilepsy business and indication unimpeded"  
[X Link](https://x.com/medtechmd/status/1927670542955397485)  2025-05-28T10:17Z [---] followers, [---] engagements


"$XYL : Xylem Initiated At JPM Price Target $148.00. A Pure Water Technology Company Gaining Increasing Global Importance"  
[X Link](https://x.com/medtechmd/status/1928395333958086943)  2025-05-30T10:17Z [---] followers, [---] engagements


"Biotech M&A Heating Up: $MRK Purportedly Offers To Acquire $MLTX"  
[X Link](https://x.com/medtechmd/status/1929649454334029915)  2025-06-02T21:20Z [---] followers, [----] engagements


"$TMDX presentation & video at WM Blair Growth Conference details the serious highly efficient nature of the OCS NOP effort & initiative"  
[X Link](https://x.com/medtechmd/status/1930014813834424415)  2025-06-03T21:32Z [---] followers, [----] engagements


"$TMDX : The Successful Transplant Statistics Resulting From The OCS NOP Initiative. $TMDX presentation & video at WM Blair Growth Conference details the serious highly efficient nature of the OCS NOP effort & initiative. https://t.co/6pxpEyyg3C $TMDX presentation & video at WM Blair Growth Conference details the serious highly efficient nature of the OCS NOP effort & initiative. https://t.co/6pxpEyyg3C"  
[X Link](https://x.com/medtechmd/status/1930015853246067068)  2025-06-03T21:36Z [---] followers, [----] engagements


"This analyst has been a skeptic of $TMDX and its role in revolutionizing the organ transplant paradigm. Always late to the game in his analysis he now jumps in"  
[X Link](https://x.com/medtechmd/status/1930227676926685298)  2025-06-04T11:38Z [---] followers, [----] engagements


"$PG: Major Force In Global Business: The Canary In The Coal Mine"  
[X Link](https://x.com/medtechmd/status/1930577483792834957)  2025-06-05T10:48Z [---] followers, [---] engagements


"Very interesting observation appearing in JAMA Ophthalmology: $LLY $NVO And for everyone else vying to enter the space"  
[X Link](https://x.com/medtechmd/status/1930978560065315058)  2025-06-06T13:22Z [---] followers, [---] engagements


"$MGTX : A Gene Therapy Company Very Undervalued By the Market"  
[X Link](https://x.com/medtechmd/status/1932018742231191844)  2025-06-09T10:15Z [---] followers, [---] engagements


"$MLTX: No credibility to acquisition interest by Merck at this time"  
[X Link](https://x.com/medtechmd/status/1932051940231508286)  2025-06-09T12:27Z [---] followers, [---] engagements


"Dr. Hussains presentation of our V007 trial data was one of only three selected for special mention by the Society of Vascular Surgery and we are delighted that the Society chose to highlight the strength of this data said Dr. Laura Niklason President and CEO of $HUMA Bio. Novel Bioengineered Vessel Outperforms AV Fistula in High Risk Patients on Hemodialysis. $HUMA Bio ATEV are a new and exciting technology in regenerative medicine that has the potential to make a great impact in how we treat a vulnerable population. https://t.co/TScN8qfKDa Novel Bioengineered Vessel Outperforms AV Fistula"  
[X Link](https://x.com/medtechmd/status/1932062378150990122)  2025-06-09T13:09Z [---] followers, [---] engagements


"The number of people dying while waiting for an organ transplant has dropped to [--] people per day on average down from [--] a few years ago. The use of extended DBD & DCD transplants by $TMDX OCS NOP shorten waiting list times for organ transplantation. The number of people dying while waiting for an organ transplant has dropped to [--] people per day on average down from [--] a few years ago. Learn about why this happened and what UNOS is doing so no one dies on the waitlist 🔗 https://t.co/gdMFIpHlvB https://t.co/b8L75E6tYz The number of people dying while waiting for an organ transplant has"  
[X Link](https://x.com/medtechmd/status/1932123489378464008)  2025-06-09T17:11Z [---] followers, [----] engagements


"Jefferies note comparing $LNTH projections vs. competitor Telix. Lets say the PSMA PET TAM is somewhere in the middle; $LNTH assumptions may turn out to be conservative"  
[X Link](https://x.com/medtechmd/status/1933294423036559379)  2025-06-12T22:44Z [---] followers, [---] engagements


"$TMDX Price Target To $150.00"  
[X Link](https://x.com/medtechmd/status/1934958994902151422)  2025-06-17T12:59Z [---] followers, [----] engagements


"The safe efficient and reliable transport of harvested DCD or extended DBD organs can be expedited utilizing $TMDX OCS NOP which the obsolete bureaucratic UNOS & OPOs are reluctant to acknowledge. Lifesaving organs should not be transported as cargo. UNOS is working to ensure organs travel in airplane cabins reducing delays and improving transplant outcomes. Learn more about our efforts to modernize organ transportation ✈ ❤ https://t.co/UfuTLFE1Km https://t.co/pTVRphiZO6 Lifesaving organs should not be transported as cargo. UNOS is working to ensure organs travel in airplane cabins reducing"  
[X Link](https://x.com/medtechmd/status/1935099326436377063)  2025-06-17T22:16Z [---] followers, [----] engagements


"$DXCM recalls more than [--] million CGM receivers for lack of audible alarm. Severe adverse events including seizure and loss of consciousness were potentially linked to the issue based on [--] reports. $ABT Freestyle Libre CGM most popular globally. https://www.medtechdive.com/news/dexcom-recall-cgm-receivers-lack-alarm/751051/ https://www.medtechdive.com/news/dexcom-recall-cgm-receivers-lack-alarm/751051/"  
[X Link](https://x.com/medtechmd/status/1935492133437284645)  2025-06-19T00:17Z [---] followers, [---] engagements


"A new liver transplantation center created at the Veterans Administration. Shows the need and importance of this indication. $TMDX : Vertically integrated to be at the forefront of this initiative unlike the foreign based competition. Creation of a new VA liver transplantation center increased access and retained care within veterans health administration https://t.co/Dnfjkx78mi Creation of a new VA liver transplantation center increased access and retained care within veterans health administration https://t.co/Dnfjkx78mi"  
[X Link](https://x.com/medtechmd/status/1935792989176987798)  2025-06-19T20:13Z [---] followers, [----] engagements


"$UTHR Performs Science Experiment On Liver Failure Patient. https://share.google/li99XUubQg1K2KM38 https://share.google/li99XUubQg1K2KM38"  
[X Link](https://x.com/medtechmd/status/1937481528834969606)  2025-06-24T12:02Z [---] followers, [---] engagements


"$BMY: U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibbs Cell Therapy Labels To Include Abecma and Breyanzi. Very Progressive Science Oriented Decision. https://news.bms.com/news/details/2025/U-S--Food-and-Drug-Administration-Approves-Streamlined-Patient-Monitoring-Requirements-and-Removal-of-REMS-Programs-within-Bristol-Myers-Squibbs-Cell-Therapy-Labels/default.aspx"  
[X Link](https://x.com/medtechmd/status/1938431359225151665)  2025-06-27T02:57Z [---] followers, [---] engagements


"Carmat files for insolvency amid cash crunch. French Artificial Heart Innovator With Viable Device Files For Insolvency. https://www.medtechdive.com/news/carmat-insolvency-france-artifical-heart/752036/ https://www.medtechdive.com/news/carmat-insolvency-france-artifical-heart/752036/"  
[X Link](https://x.com/medtechmd/status/1940134691383710064)  2025-07-01T19:45Z [---] followers, [---] engagements


"Constellation Brands : $STZ is not much worse to be fair and the Corona and Modelo brewer has great cash flow. But beer sales are not strong due to ICE raids GLP-1s gummies. Jim Cramer claims beer sales are not strong due to ICE raids How absurd is that comment"  
[X Link](https://x.com/medtechmd/status/1940764035827617824)  2025-07-03T13:26Z [---] followers, [---] engagements


"@NightOwlBiotech The narcolepsy franchise still represents 40% of the business. Once the domain of $JAZZ it is becoming a crowded space & if the Orexin story proves positive it will be devastated. I do not see how the fledgling Oncology franchise makes up for that"  
[X Link](https://x.com/medtechmd/status/1941819398676746564)  2025-07-06T11:19Z [---] followers, [--] engagements


"NTAP For Hospital Utilization Due In August NTAP in healthcare specifically New Technology Add-on Payment is a Medicare program that provides additional payments to hospitals for using innovative medical technologies that are not yet fully reimbursed through standard DRG. $HUMA $HUMA Humacyte announces Symvess ECAT Approval from U.S. Defense Logistics Agency Electronic Catalog listing approval makes Symvess available to healthcare professionals at U.S. Department of Defense and U.S. Department of Veterans Affairs facilities DURHAM N.C.July [--] $HUMA Humacyte announces Symvess ECAT Approval"  
[X Link](https://x.com/medtechmd/status/1942560206623252859)  2025-07-08T12:23Z [---] followers, [---] engagements


"XVivo Q2 [----] reveals sales dip stock plunges. $TMDX rival has quarterly shortfall and market extrapolates that to $TMDX also. The flight data is specific to TMDX & that is a better gauge of activity & the financial metrics. https://www.investing.com/news/transcripts/earnings-call-transcript-xvivo-q2-2025-reveals-sales-dip-stock-plunges-93CH-4132113 https://www.investing.com/news/transcripts/earnings-call-transcript-xvivo-q2-2025-reveals-sales-dip-stock-plunges-93CH-4132113"  
[X Link](https://x.com/medtechmd/status/1943698670995562916)  2025-07-11T15:47Z [---] followers, [----] engagements


"Understanding Donation after Circulatory Death (DCD) Nowhere in this UNOS document is $TMDX machine perfusion mentioned as a significant contributor to the success of DCD transplants & the greater availability of heart liver & lung donors. https://unos.org/news/understanding-donation-after-circulatory-death-dcd/ https://unos.org/news/understanding-donation-after-circulatory-death-dcd/"  
[X Link](https://x.com/medtechmd/status/1944837500565905898)  2025-07-14T19:12Z [---] followers, [---] engagements


"$ABT : EPS this week; best managed global healthcare device/conglomerate"  
[X Link](https://x.com/medtechmd/status/1945069329961353551)  2025-07-15T10:34Z [---] followers, [---] engagements


"The company has a rare combination of revenue and earnings growth for a company of this market cap. $TMDX: From Bill Plavonic a very experienced device analyst"  
[X Link](https://x.com/medtechmd/status/1945070481540780084)  2025-07-15T10:38Z [---] followers, [----] engagements


"Preeminent Lung Transplant Surgeon remarks on the utility of $TMDX OCS in allowing extended criteria lungs commonly rejected to be used for transplantation with good results on par with standard criteria lungs. The $TMDX lung transplant initiative begins Long-term outcomes of the international EXPAND trial of Organ Care System (OCS) Lung preservation for lung transplantation - eClinicalMedicine @TheLancet https://t.co/EZQEKa6xon @BCM_Surgery @Texas_Heart @BCMLungInst https://t.co/p6MWsj4xgM Long-term outcomes of the international EXPAND trial of Organ Care System (OCS) Lung preservation for"  
[X Link](https://x.com/medtechmd/status/1945124706819907874)  2025-07-15T14:14Z [---] followers, [----] engagements


"$MBX Once Weekly Treatment For Hypoparathyroidism vs Daily Therapeutic. Big Advantage For Patients"  
[X Link](https://x.com/medtechmd/status/1945428180912775283)  2025-07-16T10:19Z [---] followers, [----] engagements


"A lot going on at $LNTH that the market is ignoring. Represents Radiopharmaceuticals Scarcity Value"  
[X Link](https://x.com/medtechmd/status/1945445481137500242)  2025-07-16T11:28Z [---] followers, [----] engagements


"In Diabetes Care sales of continuous glucose monitors were $1.9 billion and grew [----] percent on a reported basis and [----] percent on an organic basis. $ABT FreeStyle Libre Sales Growth Of 21%"  
[X Link](https://x.com/medtechmd/status/1945810544931271158)  2025-07-17T11:39Z [---] followers, [----] engagements


"$ABT has increased its dividend payout for [--] consecutive years and is a member of the S&P [---] Dividend Aristocrats Index which tracks companies that have annually increased their dividend for at least [--] consecutive years. In Diabetes Care sales of continuous glucose monitors were $1.9 billion and grew [----] percent on a reported basis and [----] percent on an organic basis. $ABT FreeStyle Libre Sales Growth Of 21%. https://t.co/JAqSUrEK4J In Diabetes Care sales of continuous glucose monitors were $1.9 billion and grew [----] percent on a reported basis and [----] percent on an organic basis. $ABT"  
[X Link](https://x.com/medtechmd/status/1945811133262176375)  2025-07-17T11:41Z [---] followers, [---] engagements


"Despite $ABT miss in 2Q Jefferies upgrades to Buy; Price Target $145.00"  
[X Link](https://x.com/medtechmd/status/1946051285909713323)  2025-07-18T03:35Z [---] followers, [---] engagements


"@RevShark The price target numbers are meaningless. To me it is an indication of the analyst class/market sentiment and perception"  
[X Link](https://x.com/medtechmd/status/1947624093097808295)  2025-07-22T11:45Z [---] followers, [--] engagements


"$LNTH competitor $TLX Receives Subpoena From US DOJ"  
[X Link](https://x.com/medtechmd/status/1947637207235219890)  2025-07-22T12:37Z [---] followers, [----] engagements


"$HUMA Announces First Symvess Sale to Military Treatment Facility. We are excited to see the first purchase and use of Symvess by a military treatment facility said Dr. Laura Niklason President and CEO of Humacyte Inc. https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-first-symvesstm-sale-military-treatment/ https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-first-symvesstm-sale-military-treatment/"  
[X Link](https://x.com/medtechmd/status/1947992918951682359)  2025-07-23T12:11Z [---] followers, [----] engagements


"On the quarterly call analysts will probably ask which indication the SYMVESS was used for. The FDA approval is for LE trauma. This might have been utilized in an off label elective vascular procedure. $HUMA $HUMA Announces First Symvess Sale to Military Treatment Facility. We are excited to see the first purchase and use of Symvess by a military treatment facility said Dr. Laura Niklason President and CEO of Humacyte Inc. https://t.co/sPdmnYJ5nS $HUMA Announces First Symvess Sale to Military Treatment Facility. We are excited to see the first purchase and use of Symvess by a military"  
[X Link](https://x.com/medtechmd/status/1948000057124601906)  2025-07-23T12:39Z [---] followers, [---] engagements


"The Association of Organ Procurement Organizations a trade group said it is treating the concerns raised in the HHS announcement very seriously. The OPOs are responsible for this malpractice not $TMDX. These proceedings are positive for $TMDX model and DCD transplantation"  
[X Link](https://x.com/medtechmd/status/1948064705001455874)  2025-07-23T16:56Z [---] followers, [----] engagements


"$BX Reports Outstanding Quarter"  
[X Link](https://x.com/medtechmd/status/1948339673979367736)  2025-07-24T11:09Z [---] followers, [---] engagements


"Stat Article Highlighting Malpractice On Behalf Of Organ Procurement Organizations (OPOs) With Regard To Organ Donation. This Is Positive For $TMDX & Their Model"  
[X Link](https://x.com/medtechmd/status/1948342433118314512)  2025-07-24T11:20Z [---] followers, [----] engagements


"The World's Richest Woman Has Opened a Medical School $WMT heiress opens progressive medical school in Bentonville. https://time.com/7303692/alice-walton-school-of-medicine-new-medical-school/ https://time.com/7303692/alice-walton-school-of-medicine-new-medical-school/"  
[X Link](https://x.com/medtechmd/status/1949281452891283898)  2025-07-27T01:31Z [---] followers, [---] engagements


"$TMDX Competitor Will Experience 6-12 Month Full EU Approval Delay For Heart Transplant Device. Seems There Is Question Regarding The Perfusion Solution. $TMDX Utilizes Heparinized Donor Whole Blood"  
[X Link](https://x.com/medtechmd/status/1949946027961671702)  2025-07-28T21:32Z [---] followers, [----] engagements


"$NAMS Obicetrapib molecule shows promise in multiple indications. $NAMS Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimers Disease Biomarkers at AAIC [----] NewAmsterdam Pharma https://t.co/vSI0jaiPog $NAMS Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimers Disease Biomarkers at AAIC [----] NewAmsterdam Pharma https://t.co/vSI0jaiPog"  
[X Link](https://x.com/medtechmd/status/1950536029292634157)  2025-07-30T12:36Z [---] followers, [---] engagements


"$TMDX [----] Outlook: $TMDX Reports Second Quarter [----] Financial Results: https://t.co/thSV2JViyX $TMDX Reports Second Quarter [----] Financial Results: https://t.co/thSV2JViyX"  
[X Link](https://x.com/medtechmd/status/1950650377675976705)  2025-07-30T20:11Z [---] followers, [----] engagements


"$TMDX Founder and CEO Waleed Hassanein puts the Normothermic Regional Perfusion (NRP) surgical experiment fad into perspective on the quarterly conference call: There were a lot of organs and money wasted in the process"  
[X Link](https://x.com/medtechmd/status/1950666627101364459)  2025-07-30T21:15Z [---] followers, [---] engagements


"Long term clinical outcomes utilizing $TMDX OCS in DCD lung transplantation. New $TMDX initiative will reinvigorate lung transplantation. This paper examines long-term outcomes of the international EXPAND trial of organ care system lung preservation for #lungtransplant. @MVillavicencioT https://t.co/jXG1oq9SBp https://t.co/Sn07uUaUDs This paper examines long-term outcomes of the international EXPAND trial of organ care system lung preservation for #lungtransplant. @MVillavicencioT https://t.co/jXG1oq9SBp https://t.co/Sn07uUaUDs"  
[X Link](https://x.com/medtechmd/status/1950735133511717211)  2025-07-31T01:47Z [---] followers, [----] engagements


"$MSFT Joins $NVDA in $4.0 trillion club"  
[X Link](https://x.com/medtechmd/status/1950742166885572632)  2025-07-31T02:15Z [---] followers, [---] engagements


"Dr. David Altchek Mets medical director and Tommy John surgery pioneer dies at [--]. A very accomplished surgeon and certainly a driving force in sports medicine/orthopedics. IMHO his demeanor and approach was somewhat abrasive and condescending. https://www.foxsports.com/articles/mlb/dr-david-altchek-mets-medical-director-and-tommy-john-surgery-pioneer-dies-at-68 https://www.foxsports.com/articles/mlb/dr-david-altchek-mets-medical-director-and-tommy-john-surgery-pioneer-dies-at-68"  
[X Link](https://x.com/medtechmd/status/1952700827023368332)  2025-08-05T11:58Z [---] followers, [---] engagements


"Significant news out of $JEF: Longtime flamboyant $IBB analyst Michael Yee leaving for greener pastures"  
[X Link](https://x.com/medtechmd/status/1956298410786521271)  2025-08-15T10:14Z [---] followers, [---] engagements


"The Mayo Clinic makes the case for mechanical perfusion $TMDX OCS as one of the biggest technological advances in transplantation"  
[X Link](https://x.com/medtechmd/status/1956662543881031705)  2025-08-16T10:21Z [---] followers, [----] engagements


"There are approximately 100k patients on waiting lists for organ transplants in the US. This brave young lady is an example of that process. $TMDX OCS NOP for DCD & Extended DBD transplants is one way to alleviate this obsolete bureaucratic endeavor. 11-year-old girl tells her father that she is getting a new heart after waiting in the hospital for [---] days. "Daddy Im getting a heart." Ava Cooper has a new "lease on life" after she had a successful heart transplant. Cooper underwent her first heart surgery at the age of https://t.co/42yPQy32Lk 11-year-old girl tells her father that she is"  
[X Link](https://x.com/medtechmd/status/1958335772609978851)  2025-08-21T01:10Z [---] followers, [---] engagements


"Oral lipid lowering CETP molecule exhibiting impressive trial results thus far. $NAMS management has extensive clinical background/history in the space. Attractive candidate for large pharmaceutical acquisition. $45.00 PT"  
[X Link](https://x.com/medtechmd/status/1959926483008278683)  2025-08-25T10:31Z [---] followers, [--] engagements


"Terumo to buy OrganOx for $1.5B to enter transplant field. I have experience w/ the Needham analyst mentioned in this article. He was never the sharpest tool in the medical device shed. $TMDX has a big lead on this one indication pony OrganOx. https://www.medtechdive.com/news/Terumo-acquires-OrganOx-liver-transplant-device/758547/ https://www.medtechdive.com/news/Terumo-acquires-OrganOx-liver-transplant-device/758547/"  
[X Link](https://x.com/medtechmd/status/1960374215908942013)  2025-08-26T16:10Z [---] followers, [---] engagements


"$ABT absorbable below-the-knee stent nets European approval in peripheral artery disease. https://www.fiercebiotech.com/medtech/abbotts-absorbable-below-knee-stent-nets-european-approval-peripheral-artery-disease https://www.fiercebiotech.com/medtech/abbotts-absorbable-below-knee-stent-nets-european-approval-peripheral-artery-disease"  
[X Link](https://x.com/medtechmd/status/1960732931032289288)  2025-08-27T15:55Z [---] followers, [---] engagements


"$TMDX OCS NOP flights to Moscow and Beijing"  
[X Link](https://x.com/medtechmd/status/1963401650669781240)  2025-09-04T00:40Z [---] followers, [----] engagements


"$HUMA Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications. The value of Symvess lies in sparing the patient the additional surgical time of saphenous vein harvest while still avoiding the use of a plastic vessel https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-publication-outcomes-patients-hospital/ https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-publication-outcomes-patients-hospital/"  
[X Link](https://x.com/medtechmd/status/1967549992295412066)  2025-09-15T11:24Z [---] followers, [---] engagements


"If $RAPP Phase [--] Results Hold Up In Their Upcoming Phase [--] Trial This Will Be A Transformational Drug For Focal Epilepsy Patients"  
[X Link](https://x.com/medtechmd/status/1967906269714673732)  2025-09-16T10:59Z [---] followers, [---] engagements


"$HUMA Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft The CTEV has the potential to address a significant unmet clinical need in coronary bypass surgery and ultimately improve patient outcomes. https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-publication-preclinical-data-use-ctev/ https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-publication-preclinical-data-use-ctev/"  
[X Link](https://x.com/medtechmd/status/1968636792757686753)  2025-09-18T11:22Z [---] followers, [---] engagements


"Here is Cowens take on the HHS initiative regarding organ transplantation in the American healthcare system. Drs. Oz & Makary are esteemed surgeons and appreciate $TMDX technology & value in the organ transplantation realm. Upending the obsolete bureaucratic OPOs"  
[X Link](https://x.com/medtechmd/status/1968770575259648043)  2025-09-18T20:14Z [---] followers, [----] engagements


"#CharlieKirk @TPUSA Heres how Michael Gibney editor of @PharmaVoice described the late Charlie Kirk: as aright-wing provocateur. He also opined in his biased manner his view of the current political atmosphere. This publication is operated by Informa Tech Target Inc. https://t.co/Nft7bkpnRS Heres how Michael Gibney editor of @PharmaVoice described the late Charlie Kirk: as aright-wing provocateur. He also opined in his biased manner his view of the current political atmosphere. This publication is operated by Informa Tech Target Inc. https://t.co/Nft7bkpnRS"  
[X Link](https://x.com/medtechmd/status/1968775330841112876)  2025-09-18T20:33Z [---] followers, [---] engagements


"Jefferies take on $AKRO : BUY: $42.18 PT: $75.00 % to PT: +78% This molecule may have the ability to reverse hepatic fibrosis leading to end stage cirrhosis"  
[X Link](https://x.com/medtechmd/status/1968868145684189438)  2025-09-19T02:42Z [---] followers, [----] engagements


"White House press conference reported to be Monday 9/22 on Tylenol implications and Autism. $KVUE"  
[X Link](https://x.com/medtechmd/status/1969929516593369403)  2025-09-22T00:59Z [---] followers, [---] engagements


"$TMDX and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy $TMDX branching out to bring lifesaving cutting edge technology to Europe starting in Italy https://investors.transmedics.com/news-releases/news-release-details/transmedics-and-mercedes-benz-announce-strategic-collaboration/ https://investors.transmedics.com/news-releases/news-release-details/transmedics-and-mercedes-benz-announce-strategic-collaboration/"  
[X Link](https://x.com/medtechmd/status/1970067601461023228)  2025-09-22T10:08Z [---] followers, [---] engagements


"Once weekly dosing a big advantage for patients if $MBX results hold up In phase [--] trials"  
[X Link](https://x.com/medtechmd/status/1970128267047735376)  2025-09-22T14:09Z [---] followers, [----] engagements


"Having actually examined patients suffering from hypoparathyroidism unlike the short sellers it is a disease entity not easily controlled. The following comment from the hypoparathyroidism patient advocacy group says it all regarding $MBX trial results:"  
[X Link](https://x.com/medtechmd/status/1970231309449478344)  2025-09-22T20:58Z [---] followers, [---] engagements


"How SS Innovations is expanding robotic surgerys reach Very interesting story regarding a cheaper robotic surgery platform conceived & manufactured in India. Possibly coming soon to a hospital or ASC near you. $ISRG will soon have competitors on price. https://www.medtechdive.com/news/SS-Innovations-robotic-surgery-Mantra-Sudhir-Srivastava/760677/ https://www.medtechdive.com/news/SS-Innovations-robotic-surgery-Mantra-Sudhir-Srivastava/760677/"  
[X Link](https://x.com/medtechmd/status/1970298146820661539)  2025-09-23T01:24Z [---] followers, [---] engagements


"It is about time the rest of world pays the same drug prices patients pay in the US. The problem is the UK is renowned for rejecting drug availability based on price through National Institute for Health and Care Excellence or NICE. $BMY"  
[X Link](https://x.com/medtechmd/status/1970302207607054772)  2025-09-23T01:40Z [---] followers, [---] engagements


"$LLY CEO Telling It Like It IsRegarding Drug Pricing In The UK. https://share.google/5XIfL6sma7uL5d0WX https://share.google/5XIfL6sma7uL5d0WX"  
[X Link](https://x.com/medtechmd/status/1970801083241968106)  2025-09-24T10:42Z [---] followers, [---] engagements


"A safe and very effective drug administered once weekly is a big differentiating factor versus the standard of care. Positive comments and response from the sell side far outweigh the negative. $MBX Canvuparatide"  
[X Link](https://x.com/medtechmd/status/1970817900715106586)  2025-09-24T11:49Z [---] followers, [---] engagements


"$BMY Builds on Eliquis (apixaban) Direct-to-Patient Program Announces New BMS Patient Connect Platform Offering Sotyktu (deucravacitinib). Very proactive decisive move by BMY to offer DTC in an attempt to get out in front of the Trump administration. https://news.bms.com/news/details/2025/Bristol-Myers-Squibb-Builds-on-Eliquis-apixaban-Direct-to-Patient-Program-Announces-New-BMS-Patient-Connect-Platform-Offering-Sotyktu-deucravacitinib/default.aspx"  
[X Link](https://x.com/medtechmd/status/1971174730053943432)  2025-09-25T11:27Z [---] followers, [---] engagements


"Jefferies take on Trump administration drug pricing initiative: Net net we think this is a win for Pharma. $BMY $PFE $LLY $MRK $ABBV $JNJ"  
[X Link](https://x.com/medtechmd/status/1971514917221204355)  2025-09-26T09:59Z [---] followers, [---] engagements


"Excerpt Jefferies $MBX note Ph [--] results w/Canvuparatide. Once weekly SQ w/ good efficacy & safety vs daily competitor will be well received by patients. We are thrilled with these trial results said Patty Keating Executive Director of the HypoPARAthyroidism Association"  
[X Link](https://x.com/medtechmd/status/1972338019387703383)  2025-09-28T16:30Z [---] followers, [---] engagements


"$MBX price target $66 from $$36. Excerpt Jefferies $MBX note Ph [--] results w/Canvuparatide. Once weekly SQ w/ good efficacy & safety vs daily competitor will be well received by patients. We are thrilled with these trial results said Patty Keating Executive Director of the HypoPARAthyroidism Association. https://t.co/PMdCl308g7 Excerpt Jefferies $MBX note Ph [--] results w/Canvuparatide. Once weekly SQ w/ good efficacy & safety vs daily competitor will be well received by patients. We are thrilled with these trial results said Patty Keating Executive Director of the HypoPARAthyroidism"  
[X Link](https://x.com/medtechmd/status/1972338559299571856)  2025-09-28T16:32Z [---] followers, [---] engagements


"Jefferies take on $PFE drug initiative: To us this represents a win for PFE & signals a broader positive outcome for the industry as it may finally resolve the regulatory overhang tied to tariffs/MFN. $MRK $ABBV $BMY"  
[X Link](https://x.com/medtechmd/status/1973341802985038106)  2025-10-01T10:58Z [---] followers, [---] engagements


"$HUMA Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess: After up to [--] months of follow-up patients were observed to have zero infections amputations or deaths and a high rate of patency https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-publication-long-term-results-ukrainian/ https://humacyte.gcs-web.com/news-releases/news-release-details/humacyte-announces-publication-long-term-results-ukrainian/"  
[X Link](https://x.com/medtechmd/status/1975172608921420076)  2025-10-06T12:13Z [---] followers, [---] engagements


"Final Trial Data Show Success for $KURA Ziftomenib in NPM1 AML: ziftomenib was well tolerated with manageable differentiation syndrome lack of clinically significant QTc prolongation and low rates of myelosuppression. https://www.targetedonc.com/view/final-trial-data-shows-success-for-ziftomenib-in-npm1-aml https://www.targetedonc.com/view/final-trial-data-shows-success-for-ziftomenib-in-npm1-aml"  
[X Link](https://x.com/medtechmd/status/1975306503679627356)  2025-10-06T21:05Z [---] followers, [---] engagements


"$AKRO to be acquired by $NVO"  
[X Link](https://x.com/medtechmd/status/1976228088108417133)  2025-10-09T10:07Z [---] followers, [---] engagements


"$ABT initiated with a Buy at Benchmark: Benchmark initiated coverage of Abbott with a Buy rating and $145 price target Best managed global healthcare conglomerate"  
[X Link](https://x.com/medtechmd/status/1976599126797414546)  2025-10-10T10:42Z [---] followers, [---] engagements


"Jefferies initiates $TMDX at BUY with price target $145.00. A pioneer in organ transplants"  
[X Link](https://x.com/medtechmd/status/1977578565341417855)  2025-10-13T03:34Z [---] followers, [----] engagements


"In Diabetes Care sales of continuous glucose monitors were $2.0 billion and grew [----] percent on a reported basis and [----] percent on an organic basis. $ABT : Diagnostic business especially from China a drag on the business but overall a steady reliable performer"  
[X Link](https://x.com/medtechmd/status/1978427515560415616)  2025-10-15T11:47Z [---] followers, [---] engagements


"@ReformedBroker Thanks for DVYE and FM candor. Interesting fund Saturday Barron's JNBAX any ETF mimics this fund Thanks appreciate opinion"  
[X Link](https://x.com/medtechmd/status/288028724669067265)  2013-01-06T21:06Z [---] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing